Lai-Yang Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lai-Yang Lee has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Andrew J. Daley
Department of General Medicine, Infectious Diseases and Laboratory Services, The Royal Children's Hospital Melbourne, Parkville, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia
1 shared publication - Suzanne Marie Garland
Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, Vic, Australia. Centre for Women’s Infectious Diseases, The Royal Women’s Hospital, Melbourne, Vic, Australia
1 shared publication
Latest Publications
- Open Access
- 12 June 2017
- Published by F1000 Research Ltd in F1000Research
- Vol. 6, 866
Human papillomavirus vaccination: the population impact
We currently have the knowledge and experience to prevent much of human papillomavirus (HPV)-related disease burden globally. In many countries where prophylactic HPV vaccination programs have been adopted as highly effective public health programs with good vaccine coverage, we are already seeing, in real-world settings, reduction of vaccine-related HPV-type infections, genital warts and cervical pre-cancers with potential reductions in vulvar, vaginal and anal pre-cancers. Moreover, we are seeing a change in cervical screening paradigms, as HPV-based screening programs now have strong evidence to support their use as more sensitive ways to detect underlying cervical abnormalities, as compared with conventional cervical cytology. This article describes the impact of prophylactic vaccination on these outcomes and in settings where these vaccines have been implemented in national immunisation programs. Given the successes seen to date and the availability of essential tools, there has been a global push to ensure that every woman has access to effective cervical screening and every girl has the opportunity for primary prevention through vaccination. A gender-neutral approach by offering vaccination to young boys has also been adopted by some countries and is worthy of consideration given that HPV-related cancers also affect males. Furthermore, vaccination of young boys has the advantage of reducing the risk of HPV transmission to sexual partners, lowering the infectious pool of HPV in the general population and ultimately HPV-related diseases for both genders. Therefore, it is appropriate that all countries consider and promote national guidelines and programs to prevent HPV-related diseases.
- 12 June 2017
- Published by F1000 Research Ltd in F1000Research
- Vol. 6, 866
Open AccessHuman papillomavirus vaccination: the population impact
We currently have the knowledge and experience to prevent much of human papillomavirus (HPV)-related disease burden globally. In many countries where prophylactic HPV vaccination programs have been adopted as highly effective public health programs with good vaccine coverage, we are already seeing, in real-world settings, reduction of vaccine-related HPV-type infections, genital warts and cervical pre-cancers with potential reductions in vulvar, vaginal and anal pre-cancers. Moreover, we are seeing a change in cervical screening paradigms, as HPV-based screening programs now have strong evidence to support their use as more sensitive ways to detect underlying cervical abnormalities, as compared with conventional cervical cytology. This article describes the impact of prophylactic vaccination on these outcomes and in settings where these vaccines have been implemented in national immunisation programs. Given the successes seen to date and the availability of essential tools, there has been a global push to ensure that every woman has access to effective cervical screening and every girl has the opportunity for primary prevention through vaccination. A gender-neutral approach by offering vaccination to young boys has also been adopted by some countries and is worthy of consideration given that HPV-related cancers also affect males. Furthermore, vaccination of young boys has the advantage of reducing the risk of HPV transmission to sexual partners, lowering the infectious pool of HPV in the general population and ultimately HPV-related diseases for both genders. Therefore, it is appropriate that all countries consider and promote national guidelines and programs to prevent HPV-related diseases.
- Open Access
- 3 April 2017
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 53 (4) , 429
Is there more to a normal cerebrospinal fluid cell count?
- 3 April 2017
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 53 (4) , 429
Open AccessIs there more to a normal cerebrospinal fluid cell count?